Mechanically Expanded vs Self-Expanding TAVR in AS Mechanically Expanded Valves May be a Useful Addition for TAVR

The use of mechanically expandable valves was not inferior to self-expandable valves in high risk patients with severe aortic stenosis enrolled in the REPRISE III clinical trial. The trial results support the potential for the first generation LOTUS valve to become part of regular clinical practice. Continue reading

Mortality in PCI Patients With Incomplete Revascularization

In a recent retrospective observational study published in JAMA Cardiology, patients that underwent percutaneous coronary interventions with incomplete revascularization were at higher risk of mortality if they had at least 90% stenosis in an incompletely revascularized vessel, incomplete revascularization in 2 or more vessels, or proximal left anterior descending artery incomplete revascularization. Continue reading

Outcomes with Primary Angioplasty and Prasugrel vs Ticagrelor

Dr. C. Michael Gibson discusses the trial findings with Dr. Zuzana Motovska and Dr. Ota Hlinomaz at AHA 2017

Opportunities and Challenges for the Cardiovascular Interventionalists

Dr. Christopher White and Dr. C. Michael Gibson Discuss

T4V Launch and Transradial for CHIP/CTO

Dr. Sunil Rao, Dr. Adhir Shroff and Dr. C. Michael Gibson Discuss

State of the Art in BVS

Dr. Sahil Parikh and Dr. C. Michael Gibson Discuss

Outcomes of Radial vs. Femoral-Access Robotic PCI

Dr. Ehtisham Mahmud and Dr. C. Michael Gibson Discuss

Everolimus-Eluting Bioresorbable Vascular Scaffolds in CAD

Dr. Stephen Ellis and Dr. C. Michael Gibson Discuss